BackF-star Therapeutics Overview

F-star Therapeutics Net Income

Profitability analysis for FSTX.

Quarterly Net Income

-$18.47M
71.13% YoY

As of Sep 2022

Annual Net Income (TTM)

-$44.99M
0.3% YoY

Trailing 12 months ending Sep 2022

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...